Works by Dong Hoon Suh

Results: 114
    1
    2
    3
    4

    Effectiveness of adjuvant treatment for morcellated, International Federation of Gynecology and Obstetrics stage I uterine leiomyosarcoma: A Korean multicenter study.

    Published in:
    Journal of Obstetrics & Gynaecology Research, 2020, v. 46, n. 2, p. 337, doi. 10.1111/jog.14171
    By:
    • Kim, Se Ik;
    • Choi, Chel Hun;
    • Kim, Kidong;
    • Hong, Deok Ho;
    • Park, Jeong‐Yeol;
    • Kwon, Byung Su;
    • Lee, Keun Ho;
    • Hong, Dae Gy;
    • Shin, So‐Jin;
    • Park, Sang‐Il;
    • Kim, Yun Hwan;
    • Lee, Seung‐Ho;
    • Lee, Sanghoon;
    • Hong, Jin Hwa;
    • Lee, Jung‐Yun;
    • Kim, Yong Beom;
    • No, Jae Hong;
    • Suh, Dong Hoon
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Comparison of Outcomes in Bowel Resections by Gynecologic Oncologists Versus General Surgeons During Maximal Cytoreductive Surgery for Advanced Ovarian Cancer: Gynecologic Oncology Research Investigators Collaboration Study (GORILLA-3006).

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2024, v. 31, n. 9, p. 6040, doi. 10.1245/s10434-024-15643-9
    By:
    • Kim, Myeong-Seon;
    • Lee, A. Jin;
    • Shim, Seung-Hyuk;
    • Jang, Eun Bi;
    • Kim, Nam Kyeong;
    • Kim, Min Kyung;
    • Suh, Dong Hoon;
    • Kim, Jeeyeon;
    • Son, Joo-Hyuk;
    • Kong, Tae-Wook;
    • Chang, Suk-Joon;
    • Hwang, Dong Won;
    • Park, Soo Jin;
    • Kim, Hee Seung;
    • Yoo, Ji Geun;
    • Lee, Sung Jong;
    • Lee, Yoo-Young
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Optimum selection criteria for secondary cytoreductive surgery in patients with recurrent epithelial ovarian cancer: A multicenter study from the Gynecologic Oncology Research Investigators coLLaborAtion group (GORILLA‐3001).

    Published in:
    Journal of Surgical Oncology, 2023, v. 128, n. 4, p. 645, doi. 10.1002/jso.27303
    By:
    • Son, Joo‐Hyuk;
    • Kong, Tae‐Wook;
    • Park, Soo Jin;
    • Lee, Eun Ji;
    • Kim, Hee Seung;
    • Kim, Nam Kyeong;
    • Kim, Yeorae;
    • Hwang, Woo Yeon;
    • Suh, Dong Hoon;
    • Kim, Tae Hun;
    • Yang, Eun Jung;
    • Shim, Seung‐Hyuk;
    • Chang, Suk‐Joon
    Publication type:
    Article
    23
    24
    25
    26
    27
    28

    Gastrointestinal/genitourinary perforation and fistula formation with or without bevacizumab in patients with previously irradiated recurrent cervical cancer: a Korean multicenter retrospective study of the Gynecologic Oncology Research Investigators Collaboration (GORILLA) group (GORILLA-1001).

    Published in:
    2022
    By:
    • Hwang, Woo Yeon;
    • Chang, Suk-Joon;
    • Kim, Hee Seung;
    • Kim, Nam Kyeong;
    • Kim, Tae Hun;
    • Kim, Yeorae;
    • Kong, Tae Wook;
    • Lee, Eun Ji;
    • Park, Soo Jin;
    • Shim, Seung Hyuk;
    • Son, Joo-Hyuk;
    • Suh, Dong Hoon;
    • Yang, Eun Jung
    Publication type:
    journal article
    29
    30
    31
    32
    33
    34
    35
    36
    37

    Real-World Experience of Pembrolizumab Monotherapy in Patients with Recurrent or Persistent Cervical Cancer: A Korean Multi-Center Retrospective Study (KGOG1041).

    Published in:
    Cancers, 2020, v. 12, n. 11, p. 3188, doi. 10.3390/cancers12113188
    By:
    • Choi, Min Chul;
    • Kim, Yong-Man;
    • Lee, Jeong-Won;
    • Lee, Yong Jae;
    • Suh, Dong Hoon;
    • Lee, Sung Jong;
    • Lee, Taek Sang;
    • Lee, Maria;
    • Park, Dong Choon;
    • Kim, Min Kyu;
    • Lee, Jong-Min;
    • Shim, Seung-Hyuk;
    • Jeon, Seob;
    • Min, Kyung Jin;
    • Kim, Mi Kyung;
    • Kim, Bo Wook;
    • Park, Jeong Yeol;
    • Kim, Byoung-Gie;
    • Kim, Dae Yeon;
    • Kim, Moon-Hong
    Publication type:
    Article
    38
    39
    40

    Risk factors for the failure of first‐line PARP inhibitor maintenance therapy in patients with advanced ovarian cancer: Gynecologic Oncology Research Investigators Collaboration Study (GORILLA‐3004).

    Published in:
    Cancer Medicine, 2023, v. 12, n. 19, p. 19449, doi. 10.1002/cam4.6546
    By:
    • Kim, Nam Kyeong;
    • Kim, Yeorae;
    • Kim, Hee Seung;
    • Park, Soo Jin;
    • Hwang, Dong Won;
    • Lee, Sung Jong;
    • Yoo, Ji Geun;
    • Chang, Suk‐Joon;
    • Son, Joo‐Hyuk;
    • Kong, Tae‐Wook;
    • Kim, Jeeyeon;
    • Shim, Seung‐Hyuk;
    • Lee, A Jin;
    • Suh, Dong Hoon;
    • Lee, Yoo‐Young
    Publication type:
    Article
    41
    42
    43
    44
    45
    46

    Communicating BRCA research results to patients enrolled in international clinical trials: lessons learnt from the AGO-OVAR 16 study.

    Published in:
    2016
    By:
    • Pulford, David J;
    • Harter, Philipp;
    • Floquet, Anne;
    • Barrett, Catherine;
    • Suh, Dong Hoon;
    • Friedlander, Michael;
    • Arranz, José Angel;
    • Hasegawa, Kosei;
    • Tada, Hiroomi;
    • Vuylsteke, Peter;
    • Mirza, Mansoor R;
    • Donadello, Nicoletta;
    • Scambia, Giovanni;
    • Johnson, Toby;
    • Cox, Charles;
    • Chan, John K;
    • Imhof, Martin;
    • Herzog, Thomas J;
    • Calvert, Paula;
    • Wimberger, Pauline
    Publication type:
    journal article
    47

    Communicating research results to BRCA patients enrolled in international clinical trials: lessons learnt from the AGO-OVAR 16 study.

    Published in:
    BMC Medical Ethics, 2016, v. 17, p. 1, doi. 10.1186/s12910-016-0144-y
    By:
    • Pulford, David J.;
    • Harter, Philipp;
    • Floquet, Anne;
    • Barrett, Catherine;
    • Dong Hoon Suh;
    • Friedlander, Michael;
    • Arranz, José Angel;
    • Kosei Hasegawa;
    • Hiroomi Tada;
    • Vuylsteke, Peter;
    • Mirza, Mansoor R.;
    • Donadello, Nicoletta;
    • Scambia, Giovanni;
    • Johnson, Toby;
    • Cox, Charles;
    • Chan, John K.;
    • Imhof, Martin;
    • Herzog, Thomas J.;
    • Calvert, Paula;
    • Wimberger, Pauline
    Publication type:
    Article
    48
    49
    50